Filing Details

Accession Number:
0001181431-13-033069
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-05 18:09:53
Reporting Period:
2013-06-04
Filing Date:
2013-06-05
Accepted Time:
2013-06-05 18:09:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302106 D Ryan Drant 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-04 1,645,000 $0.00 9,854,255 No 4 J Indirect See Note 2
Common Stock Acquisiton 2013-06-04 16,450 $0.00 16,450 No 4 J Indirect See Note 4
Common Stock Disposition 2013-06-04 16,450 $0.00 0 No 4 J Indirect See Note 4
Common Stock Acquisiton 2013-06-04 580 $0.00 580 No 4 J Direct
Common Stock Acquisiton 2013-06-04 3,583 $0.00 3,583 No 4 J Indirect See Note 8
Common Stock Disposition 2013-06-05 3,583 $39.00 0 No 4 S Indirect See Note 8
Common Stock Disposition 2013-06-05 580 $40.17 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect See Note 2
No 4 J Indirect See Note 4
No 4 J Indirect See Note 4
No 4 J Direct
No 4 J Indirect See Note 8
No 4 S Indirect See Note 8
No 4 S Direct
Footnotes
  1. New Enterprise Associates 13, Limited Partnership ("NEA 13") made a pro rata distribution for no consideration of an aggregate of 1,645,000 shares of common stock of the Issuer to its general partner and its limited partners on June 4, 2013.
  2. The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of NEA 13, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the shares held by NEA 13, except to the extent of his pecuniary interest therein.
  3. NEA Partners 13 received 16,450 shares of common stock of the Issuer in the distribution by NEA 13 on June 4, 2013.
  4. The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the shares held by NEA Partners 13, except to the extent of his pecuniary interest therein.
  5. NEA Partners 13 made a pro rata distribution for no consideration of an aggregate of 16,450 shares of common stock of the Issuer to its limited partners on June 4, 2013.
  6. The Reporting Person received 580 shares of common stock of the Issuer in the distribution by NEA Partners 13 on June 4, 2013.
  7. New Enterprise Associates, LLC ("NEA LLC") received 3,583 shares of common stock of the Issuer in the distribution by NEA Partners 13 on June 4, 2013.
  8. The Reporting Person is a member of the Board of Directors of NEA LLC, which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the shares of the Issuer held by NEA LLC, except to the extent of his pecuniary interest therein.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.65 to $39.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9) to this Form 4.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $40.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (10) to this Form 4.